Financials
- Financial year
- 2023
- Total assets
- €652,428
- Profit
- €26,120
- Solvency
- 49.3%
Total assets▲ 9.5%
Net result
20182023
APOTEEK STAES
ActiveSummary
The computed 12-month bankruptcy probability of APOTEEK STAES is 4.6% (elevated). For APOTEEK STAES, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €321,468 and a net result of €26,120. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 64% of 9,449 sector peers (NACE 47, financial year 2023). The company has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€652,428total assets 2023
- Staff
- 1.4 FTE
- Equity
- €321,468
- Profit
- €26,120
Turnover not published (abbreviated format)
Financial health
- Bankruptcy probabilitywithin 12 months
- 4.6%
2023 figures too old to score
Structure
Accounts 435 days overdue0 of 5 deeds read
Signalsraises riskFigures for financial year 2023 (filed 26-08-2024)2 financial years not filed after the legal deadline; latest accounts 25 days lateLiquidity: current ratio 1.06, cash €3,834Two or more financial years not filedlowers riskFounded in 1987neutralFiled after the deadlineShow the evidence
Bankruptcy probability
No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Bankruptcy probability: Elevated
Filing: At least two filing cycles are missing
Financial strength, FY 2023 · tick = 2022
Average
Solvency
74-1
equity 49.3% of total assets
Liquidity
29-3
short-term debt 44.7% · cash 0.6%
Profitability
59-17
return on assets 4.0%
Bankruptcy probability, 12 months
4.6%
Elevated
0%0.5%1.5%4%10%≥ 25%
About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.2%
12-2024: 0.2%● unchanged vs 11-2024
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025lowest value
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.3%▲ +0.1 percentage points vs 05-2025
07-2025: 0.4%▲ +0.1 percentage points vs 06-2025
08-2025: 0.7%▲ +0.3 percentage points vs 07-2025
09-2025: 0.8%▲ +0.1 percentage points vs 08-2025
10-2025: 1.3%▲ +0.5 percentage points vs 09-2025
11-2025: 1.3%● unchanged vs 10-2025
12-2025: 1.7%▲ +0.4 percentage points vs 11-2025
01-2026: 3.1%▲ +1.4 percentage points vs 12-2025
02-2026: 3.1%● unchanged vs 01-2026
03-2026: 3.3%▲ +0.2 percentage points vs 02-2026
04-2026: 3.0%▼ -0.3 percentage points vs 03-2026
05-2026: 3.0%● unchanged vs 04-2026
06-2026: 3.0%● unchanged vs 05-2026
07-2026: 3.0%● unchanged vs 06-2026
08-2026: 4.1%▲ +1.1 percentage points vs 07-2026
09-2026: 4.6%▲ +0.5 percentage points vs 08-2026highest value
10-2026: 4.6%● unchanged vs 09-2026highest value
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
−lowers risk+raises risk○neutral
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filingsPosition against the passed deadline
31-12-2024 year end31-07-2025 deadline09-10-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 25-08-2024, 25 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
25 days late
2022
25 days late
2021
3 days early
2020
11 days late
2019
108 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 33 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
- Annual accounts filedfinancial year 2023 · abbreviated…
- Annual accounts filedfinancial year 2022 · abbreviated…
- Annual accounts filedfinancial year 2021 · abbreviated…
Key points
By topic
Timeline
- Events
- 39
- Since
- 1988
- 31-12-2021Highest result from 2018 to 2023
- 11-08-2021Annual accounts filed
- 31-12-2020Back to profit
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 14-01-1987
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.